Early Pregnancy Loss
15
2
5
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.7%
1 terminated out of 15 trials
87.5%
+0.9% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 7 completed trials
Clinical Trials (15)
Letrozole and Misoprostol for Early Pregnancy Loss Management
Factors Influencing Fertility or Pregnancy Health
Interest of Simulation Training on the Announcement of Early Pregnancy Loss on the Psychological Impact of the Patients
Surgical vs. Medical Abortion on Sexual Function After Early Pregnancy Loss
Virtual Reality for Coping With Involuntary Early Pregnancy Loss
EARLY-PREG: A Preconception Cohort Study Based on Counterfactuals to Study Maternal-Embryonic Molecular Interactions
Conversational Artificial Intelligence (AI) to Improve PeRiconception Care Access
Optimal Time Interval Between Mifepristone and Misoprostol Administration for Early Pregnancy Loss
Operative Hysteroscopy Versus Suction Curettage for Surgical Termination of Early Pregnancy Loss (Miscarriage)
Cohort of Patients Presenting Unexplained Recurrent Miscarriages and Identification of Early Miscarriage Recidivism Factors
Beta-HCG Levels in Uterine Cavity Lavage for Pregnancies of Unknown Location
Cell-free DNA Analysis of Chromosome Anomalies in Early Pregnancy Loss
A Follow-up of the Early Pregnancy Study Cohort.
Assessment of Biomarkers in Pregnancy on Unknown Location and Ectopic Pregnancy
Evaluation of a Decision Aid for Early Pregnancy Loss